Modulation of renal EGF in dichromate-induced acute renal failure treated with thyroid hormone
- 1 June 1994
- journal article
- Published by Elsevier in Kidney International
- Vol. 45 (6) , 1622-1627
- https://doi.org/10.1038/ki.1994.213
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Increased soluble EGF after ischemia is accompanied by a decrease in membrane-associated precursorsAmerican Journal of Physiology-Renal Physiology, 1993
- Triiodothyronine enhances renal tubule cell replication by stimulating EGF receptor gene expressionAmerican Journal of Physiology-Renal Physiology, 1992
- Changes in gene expression after temporary renal ischemiaKidney International, 1990
- Epidermal growth factor accelerates functional recovery from ischaemic acute tubular necrosis in the rat: Role of the epidermal growth factor receptorClinical Science, 1990
- Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure.Journal of Clinical Investigation, 1989
- Reduced renal prepro-epidermal growth factor mRNA and decreased EGF excretion in ARFKidney International, 1989
- Beneficial effect of thyroxin in the treatment of ischemic acute renal failurePediatric Nephrology, 1988
- Protection by thyroxine in nephrotoxic acute renal failureAmerican Journal of Physiology-Renal Physiology, 1986
- Protective effect of thyroxine but not parathyroidectomy on gentamicin nephrotoxicityAmerican Journal of Physiology-Renal Physiology, 1985
- Beneficial effect of thyroxin on recovery from toxic acute renal failureKidney International, 1984